Polymorphism in IgA nephropathy

被引:11
作者
Liu, ZH
Li, LS
机构
关键词
angiotensin-converting enzyme gene; angiotensin II type 1 receptor gene; immune deposits; interleukin-1 receptor antagonist gene;
D O I
10.1111/j.1440-1797.1997.tb00191.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
IgA nephropathy (IgAN) is polyphormic in its clinical manifestation, course and prognosis. Patients with isolated IgA deposit in glomeruli tend to have a high incidence of macroscopic haematuria and carry a better prognosis. In contrast, patients with deposits of IgA and IgG and IgM have a higher incidence of nephrotic syndrome and hypertension. In parallel, patients with IgA and IgG and IgM tend to have more glomerulosclerosis and tubulointestitial lesions. Recently, the angiotensin converting enzyme (ACE) gene polymorphism and its association in disease risk provided interesting exploration leading us to speculate about a possible mechanism to explain the variation in the rate of progression of IgAN; although, the results are still controversial. The variability of plasma ACE concentration has been shown to be associated with an insertion/deletion polymorphism. The frequencies of ACE genotype in 177 Chinese patients with IgAN has been observed. We found that patients with IgAN showed a higher frequency of DD genotype than normal population. In contrast to the previous reports, we did not find any association between ACE genotype and the rate of progression of IgAN. As different genotypes of IL-1 receptor antagonist (IL-1ra) are also responsible for the circulating levels of IL-1ra, the polymorphism of IL-1ra gene has been analyzed in 100 IgAN patients. There was no significant difference in the frequency of IL1RN*2 allele between normal subjects and IgAN. However, patients with recurrent macroscopic haematuria showed a higher carriage rate of IL1RN*2. Hereditable factors, in combination with a number of recognized environmental risk factors, are important determinants of the pathogenesis and natural history of IgAN. The notion that the gene polymorphism might be responsible for the clinical features and progression of IgAN is both intriguing and provocative. The lessons from previous multiple small size studies have produced conflicting results illustrating the need for observation of large numbers of cases in further studies to verify these observed associations.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 32 条
[1]   THE PATHOGENETIC SIGNIFICANCE OF C5B-9 IN IGA NEPHROPATHY [J].
ALEXOPOULOS, E ;
PAPAGHIANNI, A ;
PAPADIMITRIOU, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (07) :1166-1172
[2]   Interleukin-1 receptor antagonist allele (IL1RN(*)2) associated with nephropathy in diabetes mellitus [J].
Blakemore, AIF ;
Cox, A ;
Gonzalez, AM ;
Maskill, JK ;
Hughes, ME ;
Wilson, RM ;
Ward, JD ;
Duff, GW .
HUMAN GENETICS, 1996, 97 (03) :369-374
[3]   INTERLEUKIN-1 RECEPTOR ANTAGONIST GENE POLYMORPHISM AS A DISEASE SEVERITY FACTOR IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BLAKEMORE, AIF ;
TARLOW, JK ;
CORK, MJ ;
GORDON, C ;
EMERY, P ;
DUFF, GW .
ARTHRITIS AND RHEUMATISM, 1994, 37 (09) :1380-1385
[4]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[5]   LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY IN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :247-254
[6]  
CLARKSON AR, 1984, CLIN NEPHROL, V21, P7
[7]  
CLAY FE, 1994, HUM GENET, V94, P407
[8]   GENETIC PREDISPOSITION TO DIABETIC NEPHROPATHY - EVIDENCE FOR A ROLE OF THE ANGIOTENSIN I-CONVERTING ENZYME GENE [J].
DORIA, A ;
WARRAM, JH ;
KROLEWSKI, AS .
DIABETES, 1994, 43 (05) :690-695
[9]   IGA NEPHROPATHY - MORPHOLOGIC EXPRESSION AND PATHOGENESIS [J].
EMANCIPATOR, SN .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (03) :451-462
[10]   HLA ASSOCIATIONS IN IGA NEPHROPATHY AND FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS [J].
FREEDMAN, BI ;
SPRAY, BJ ;
HEISE, ER .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (03) :352-357